Skip to content

MGC Pharmaceuticals confirms Phase II trial success for anti-inflammatory COVID treatment

CBD oil
This article is only available to ITK members and is restricted for Pharmacists. Please or Register as a Pharmacist to read the content.
Share this article:
Via Mike Cooper
Source Stockhead

Articles you might be interested in

Scroll To Top